Anders Haglund

1.6k total citations · 1 hit paper
19 papers, 1.2k citations indexed

About

Anders Haglund is a scholar working on Psychiatry and Mental health, Pharmacology and Epidemiology. According to data from OpenAlex, Anders Haglund has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 6 papers in Pharmacology and 5 papers in Epidemiology. Recurrent topics in Anders Haglund's work include Dementia and Cognitive Impairment Research (7 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Nail Diseases and Treatments (3 papers). Anders Haglund is often cited by papers focused on Dementia and Cognitive Impairment Research (7 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Nail Diseases and Treatments (3 papers). Anders Haglund collaborates with scholars based in Sweden, Finland and United States. Anders Haglund's co-authors include Bengt Winblad, A.-L. Wetterholm, Anders Wimo, Knut Engedal, Frans R.J. Verhey, Hilkka Soininen, Ponni Subbiah, Gunhild Waldemar, Lena Kilander and Lennart Minthon and has published in prestigious journals such as The Lancet, Neurology and Neurobiology of Aging.

In The Last Decade

Anders Haglund

17 papers receiving 1.2k citations

Hit Papers

A 1-year, randomized, placebo-controlled study of donepez... 2001 2026 2009 2017 2001 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
    2001 578 citations Bengt Winblad, Knut Engedal et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Haglund Sweden 10 673 507 310 191 170 19 1.2k
B. Van Baelen Germany 18 565 0.8× 301 0.6× 150 0.5× 73 0.4× 83 0.5× 31 1.0k
Helen A. Shaw United States 8 404 0.6× 264 0.5× 206 0.7× 124 0.6× 78 0.5× 17 887
SJ Edwards United Kingdom 4 373 0.6× 295 0.6× 184 0.6× 100 0.5× 69 0.4× 6 751
Maria Rosaria Barulli Italy 18 230 0.3× 162 0.3× 351 1.1× 137 0.7× 108 0.6× 38 987
G.J.M. Walstra Netherlands 16 590 0.9× 87 0.2× 352 1.1× 61 0.3× 144 0.8× 25 1.1k
Roberta Stallone Italy 13 186 0.3× 104 0.2× 397 1.3× 272 1.4× 73 0.4× 21 779
Hae Ri Na South Korea 18 352 0.5× 76 0.1× 272 0.9× 66 0.3× 121 0.7× 66 837
Qingwei Ruan China 18 295 0.4× 69 0.1× 425 1.4× 387 2.0× 125 0.7× 55 1.2k
Vijaya L. Melnick United States 4 398 0.6× 65 0.1× 319 1.0× 64 0.3× 81 0.5× 9 861
George M. Haig United States 16 571 0.8× 448 0.9× 179 0.6× 41 0.2× 24 0.1× 31 1.2k

Countries citing papers authored by Anders Haglund

Since Specialization
Citations

This map shows the geographic impact of Anders Haglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Haglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Haglund more than expected).

Fields of papers citing papers by Anders Haglund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Haglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Haglund. The network helps show where Anders Haglund may publish in the future.

Co-authorship network of co-authors of Anders Haglund

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Haglund. A scholar is included among the top collaborators of Anders Haglund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Haglund. Anders Haglund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Winblad, Bengt, Frank Jessen, Milica G. Kramberger, et al.. (2020). The IMI‐EU H2020 project MOPEAD: Outcome of different screening methods to identify MCI/early AD. Alzheimer s & Dementia. 16(S6).
2.
Haglund, Anders & Per Axelsson. (2017). The Invisible Sami Population. 10(2). 123–145.
3.
El‐Galaly, Tarec Christoffer, Karen Juul Mylam, Maria Rossing, et al.. (2013). Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse. Hematological Oncology. 31. 1 indexed citations
4.
Malmberg, Bo, et al.. (2011). KUD – a scale for clinical evaluation of moderate‐to‐severe dementia. Journal of Clinical Nursing. 20(11-12). 1542–1552. 6 indexed citations
5.
Jelić, Vesna, Anders Haglund, Jan Kowalski, Sven Langworth, & Bengt Winblad. (2008). Donepezil Treatment of Severe Alzheimer’s Disease in Nursing Home Settings. A Responder Analysis. Dementia and Geriatric Cognitive Disorders. 26(5). 458–466. 15 indexed citations
6.
Winblad, Bengt, Anders Wimo, Knut Engedal, et al.. (2006). 3-Year Study of Donepezil Therapy in Alzheimer’s Disease: Effects of Early and Continuous Therapy. Dementia and Geriatric Cognitive Disorders. 21(5-6). 353–363. 137 indexed citations
7.
Winblad, Bengt, Lena Kilander, Sture Eriksson, et al.. (2006). Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. The Lancet. 367(9516). 1057–1065. 281 indexed citations
8.
9.
Winblad, Bengt, Anders Wimo, A.-L. Wetterholm, et al.. (2003). P.4.044 Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study. European Neuropsychopharmacology. 13. S404–S404. 1 indexed citations
10.
Wimo, Anders, Bengt Winblad, Knut Engedal, et al.. (2002). An Economic Evaluation of Donepezil in Mild to Moderate Alzheimer’s Disease: Results of a 1-Year, Double-Blind, Randomized Trial. Dementia and Geriatric Cognitive Disorders. 15(1). 44–54. 85 indexed citations
11.
Winblad, Bengt, Knut Engedal, Hilkka Soininen, et al.. (2001). A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology. 57(3). 489–495. 578 indexed citations breakdown →
12.
Wimo, Anders, Bengt Winblad, Vera Mastey, et al.. (2000). An economic evaluation of donepezil in mild to moderate Alzheimer's disease: Results of a one-year, double-blind, randomized trial. Neurobiology of Aging. 21. 63–63. 8 indexed citations
13.
Engedal, Knut, Hilkka Soininen, Frans R.J. Verhey, et al.. (2000). Donepezil improved or stabilized cognition over one year in patients with mild and moderate Alzheimer's disease. European Neuropsychopharmacology. 10. 368–368. 6 indexed citations
14.
Faergemann, Jan, et al.. (1997). A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris.. PubMed. 136(4). 575–7. 26 indexed citations
15.
16.
17.
Rodríguez‐Martínez, Heriberto, et al.. (1995). Ultrastructure of the secretory endometrium during oestrus in young maiden and foaled mares. Equine Veterinary Journal. 27(5). 382–388. 29 indexed citations
18.
Osser, S., Anders Haglund, L Weström, et al.. (1991). Treatment of candidal vaginitis: A prospective randomized investigator‐blind multicenter study comparing topically applied econazole with oral fluconazole. Acta Obstetricia Et Gynecologica Scandinavica. 70(1). 73–78. 22 indexed citations
19.
Wilhelmsson, L., et al.. (1985). PIROXICAM IN THE TREATMENT OF PRIMARY DYSMENORRHEA. Acta Obstetricia Et Gynecologica Scandinavica. 64(4). 317–321. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Van Baelen Breakdown of academic impact, for papers by Helen A. Shaw Breakdown of academic impact, for papers by SJ Edwards Breakdown of academic impact, for papers by Maria Rosaria Barulli Breakdown of academic impact, for papers by G.J.M. Walstra Breakdown of academic impact, for papers by Roberta Stallone Breakdown of academic impact, for papers by Hae Ri Na Breakdown of academic impact, for papers by Qingwei Ruan Breakdown of academic impact, for papers by Vijaya L. Melnick Breakdown of academic impact, for papers by George M. Haig
Rankless by CCL
2026